181. Biotech post-covid. Merck spende 11 miliardi per dominare il futuro

from AtGlancEconomix · host Francesco Zambelli

Mentre tutti scappano dal settore biotech dopo la fine della pandemia, il colosso tedesco Merck mette sul tavolo 11,3 miliardi di dollari per comprare un'azienda americana che ha perso metà del suo valore. Dietro questa mossa apparentemente folle si nasconde una strategia geniale per controllare chi farà le medicine del futuro. Premi 'play' e scoprilo in meno di 5 minuti!---FONTE:- Fonte 1: https://www.ft.com/content/4d5030cb-a61e-4d15-a5b5-c4c7c6bca471?syn-25a6b1a6=1🎧Spotify ➡️: https://bit.ly/4e5t6sChttps://www.linkedin.com/in/francescozambellihttps://youtube.com/@francesco_zambellihttps://www.instagram.com/atglaneconomixhttps://www.facebook.com/share/1CBxjueLvF/https://atglanceconomix.carrd.co/https://whatsapp.com/channel/0029Vb6ZcP69hXF50YnZKV06https://t.me/AtGlanEconomixhttps://www.tiktok.com/@atglanceconomix?_r=1&_t=ZN-91kwQLH2Jao

What this episode covers

NOW PLAYING

0:00 8:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AtGlancEconomix?

This episode is 8 minutes long.

When was this AtGlancEconomix episode published?

This episode was published on June 30, 2026.

What is this episode about?

Can I download this AtGlancEconomix episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!